Hormonal Circadian Rhythms in Patients with Congenital Adrenal Hyperplasia: Identifying Optimal Monitoring Times and Novel Disease Biomarkers

OBJECTIVES: The treatment goal in congenital adrenal hyperplasia (CAH) is to replace glucocorticoids while avoiding androgen excess and iatrogenic Cushing’s syndrome. However, there is no consensus on how to monitor disease control. Our main objectives were to evaluate hormonal circadian rhythms and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Endocrinol
Päätekijät: Debono, Miguel, Mallappa, Ashwini, Gounden, Verena, Nella, Aikaterini A, Harrison, Robert F, Crutchfield, Christopher A, Backlund, Peter S, Soldin, Steven J, Ross, Richard J, Merke, Deborah P
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623929/
https://ncbi.nlm.nih.gov/pubmed/26340969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-15-0064
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia